Imunon, Inc. Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Imunon, Inc. quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Imunon, Inc. Return On Equity for the quarter ending September 30, 2024 was -230 %, a 97.3% decline year-over-year.
  • Imunon, Inc. annual Return On Equity for 2023 was -98 %, a 12% decline from 2022.
  • Imunon, Inc. annual Return On Equity for 2022 was -87.6 %, a 147% decline from 2021.
  • Imunon, Inc. annual Return On Equity for 2021 was -35.5 %, a 67.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -98 -10.5 -12% Jan 1, 2023 Dec 31, 2023
2022 -87.6 -52.1 -147% Jan 1, 2022 Dec 31, 2022
2021 -35.5 +75.1 +67.9% Jan 1, 2021 Dec 31, 2021
2020 -111 -14.7 -15.3% Jan 1, 2020 Dec 31, 2020
2019 -96 -35.6 -59% Jan 1, 2019 Dec 31, 2019
2018 -60.4 +122 +66.9% Jan 1, 2018 Dec 31, 2018
2017 -182 -2.79 -1.55% Jan 1, 2017 Dec 31, 2017
2016 -180 -90.9 -102% Jan 1, 2016 Dec 31, 2016
2015 -88.7 -24 -37.2% Jan 1, 2015 Dec 31, 2015
2014 -64.7 -38.5 -147% Jan 1, 2014 Dec 31, 2014
2013 -26.2 +151 +85.2% Jan 1, 2013 Dec 31, 2013
2012 -177 +55.5 +23.8% Jan 1, 2012 Dec 31, 2012
2011 -233 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.